141 related articles for article (PubMed ID: 643903)
1. Bromocriptine and hydergine: a comparison on striatal or hypothalamic adenylate cyclase activity.
Portaleone P
Pharmacology; 1978; 16 Suppl 1():207-9. PubMed ID: 643903
[TBL] [Abstract][Full Text] [Related]
2. Effects of bromocriptine on adenylate cyclase and phosphodiesterase activities of rat striatum.
Pagnini G; Camanni F; Crispino A; Portaleone P
J Pharm Pharmacol; 1978 Feb; 30(2):92-5. PubMed ID: 24111
[TBL] [Abstract][Full Text] [Related]
3. The effect of bromocriptine on rat striatal adenylate cyclase and rat brain monoamine metabolism.
Markstein R; Herrling PL
J Neurochem; 1978 Nov; 31(5):1163-72. PubMed ID: 702165
[No Abstract] [Full Text] [Related]
4. Comparative study of the dopamine-sensitive adenylate cyclase in the striatum and hypothalamus of rat brain.
Roufogalis BD; Thornton M; Wade DN
J Pharm Pharmacol; 1979 Jan; 31(1):33-8. PubMed ID: 32363
[TBL] [Abstract][Full Text] [Related]
5. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
6. D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum.
Battaglia G; Norman AB; Hess EJ; Creese I
Neurosci Lett; 1985 Aug; 59(2):177-82. PubMed ID: 2932659
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum.
Lucchi L; Moresco RM; Govoni S; Trabucchi M
Brain Res; 1988 May; 449(1-2):347-51. PubMed ID: 2969275
[TBL] [Abstract][Full Text] [Related]
8. Senescence does not alter activation or inhibition of striatal adenylate cyclase.
Rabin RA
Neurobiol Aging; 1986; 7(1):49-51. PubMed ID: 3951659
[TBL] [Abstract][Full Text] [Related]
9. Subsensitivity of the rat striatal dopaminergic system after treatment with bromocriptine: effects on [3H]spiperone binding and dopamine-stimulated cyclic AMP formation.
Quik M; Iversen LL
Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):141-5. PubMed ID: 212684
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain.
Karobath M; Leitich H
Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2915-8. PubMed ID: 4527668
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of adenylate cyclase in rat striatum by pergolide: influence of GTP.
Rosenfeld MR; Makman MH; Goldstein M
Eur J Pharmacol; 1980 Nov; 68(1):65-8. PubMed ID: 7449835
[TBL] [Abstract][Full Text] [Related]
12. Endogenous components of the striatum confer dopamine-sensitivity upon adenylate cyclase activity: the role of endogenous guanyl nucleotides.
Chen TC; Cote TE; Kebabian JW
Brain Res; 1980 Jan; 181(1):139-49. PubMed ID: 7350949
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of dopamine sensitive adenylate cyclase from rat brain striatal homogenates by ascorbic acid.
Thomas TN; Zemp JW
J Neurochem; 1977 Mar; 28(3):663-5. PubMed ID: 853306
[No Abstract] [Full Text] [Related]
14. Distinct interactions between Ca2+/calmodulin and neurotransmitter stimulation of adenylate cyclase in striatum and hippocampus.
Ahlijanian MK; Cooper DM
Cell Mol Neurobiol; 1988 Dec; 8(4):459-69. PubMed ID: 3224361
[TBL] [Abstract][Full Text] [Related]
15. Sulfated cholecystokinin octapeptide (CCK8) failed to modulate basal or dopamine-stimulated adenylate cyclase activity in the rat striatum.
Morency MA; Ross GM; Kajiura JS; Mishra RK
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):331-6. PubMed ID: 3387592
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of dopamine-activated adenylate cyclase and dopamine binding by opiate receptors in rat striatum.
Gentleman S; Parenti M; Neff NH; Pert CB
Cell Mol Neurobiol; 1983 Mar; 3(1):17-26. PubMed ID: 6309392
[TBL] [Abstract][Full Text] [Related]
17. Effect of dopamine on activation of rat striatal adenylate cyclase by free Mg2+ and guanyl nucleotides.
McSwigan JD; Nicol SE; Gottesman II; Tuason VB; Frey WH
J Neurochem; 1980 Mar; 34(3):594-601. PubMed ID: 7354334
[No Abstract] [Full Text] [Related]
18. Muscarinic receptors modulate dopamine-activated adenylate cyclase of rat striatum.
Olianas MC; Onali P; Neff NH; Costa E
J Neurochem; 1983 Nov; 41(5):1364-9. PubMed ID: 6619871
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting solubilized dopamine-sensitive adenylate cyclase.
Marshall AM; Ramwani J; Mishra RK
Biochem Pharmacol; 1983 Apr; 32(7):1237-41. PubMed ID: 6847713
[TBL] [Abstract][Full Text] [Related]
20. Effect of butaclamol on dopamine-sensitive adenylate cyclase in the rat striatum.
Miller RJ; Horn AS; Iversen LL
J Pharm Pharmacol; 1975 Mar; 27(3):212-3. PubMed ID: 238011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
